Neurobiology of Aging
Volume 30, Issue 8 , Pages 1192-1204 , August 2009

Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer’s disease

  • Oliver Ambrée

      Affiliations

    • Department of Behavioural Biology, University of Münster, Badestrasse 9, D-48149 Münster, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 251 83 21014; fax: +49 251 83 23896.
    • ,
  • Helene Richter

      Affiliations

    • Department of Behavioural Biology, University of Münster, Badestrasse 9, D-48149 Münster, Germany
    • ,
  • Norbert Sachser

      Affiliations

    • Department of Behavioural Biology, University of Münster, Badestrasse 9, D-48149 Münster, Germany
    • ,
  • Lars Lewejohann

      Affiliations

    • Department of Behavioural Biology, University of Münster, Badestrasse 9, D-48149 Münster, Germany
    • ,
  • Ekrem Dere

      Affiliations

    • Institute of Physiological Psychology and Center for Biological and Medical Research, Heinrich-Heine University, D-40225 Düsseldorf, Germany
    • ,
  • Maria Angelica de Souza Silva

      Affiliations

    • Institute of Physiological Psychology and Center for Biological and Medical Research, Heinrich-Heine University, D-40225 Düsseldorf, Germany
    • ,
  • Arne Herring

      Affiliations

    • Institute of Neuropathology, University Hospital Münster, Domagkstrasse 19, D-48149 Münster, Germany
    • ,
  • Kathy Keyvani

      Affiliations

    • Institute of Neuropathology, University Hospital Münster, Domagkstrasse 19, D-48149 Münster, Germany
    • ,
  • Werner Paulus

      Affiliations

    • Institute of Neuropathology, University Hospital Münster, Domagkstrasse 19, D-48149 Münster, Germany
    • ,
  • Wolf-Rüdiger Schäbitz

      Affiliations

    • Institute of Neurology, University Hospital Münster, Albert-Schweitzer-Strasse 33, D-48149 Münster, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 251 83 45235; fax: +49 251 83 48181.

Received 30 May 2007 ,Revised 1 November 2007 ,Accepted 9 November 2007.

References 

  1. Ambrée O, Leimer U, Herring A, Görtz N, Sachser N, Heneka MT, et al. Reduction of amyloid angiopathy and A plaque burden after enriched housing in TgCRND8 mice: involvement of multiple pathways. Am. J. Pathol. 2006;169(2):544–552
  2. Ambrée O, Touma C, Görtz N, Keyvani K, Paulus W, Palme R, et al. Activity changes and marked stereotypic behavior precede A pathology in TgCRND8 Alzheimer mice. Neurobiol. Aging. 2006;27(7):955–964
  3. Barnes CA. Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J. Comp. Physiol. Psychol. 1979;93(1):74–104
  4. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science. 1979;205(4409):929–932
  5. Bubser M, Schmidt WJ. 6-hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze. Behav. Brain Res. 1990;37(2):157–168
  6. Cabib, S., 1993. Neurobiological basis of stereotypies. In: Lawrence, A.B., Rushen, J. (Eds.), Stereotypic Animal Behaviour: Fundamentals and Applications to Welfare. CAB International, Wallingford, pp. 119–146.
  7. Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, et al. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 2001;276(24):21562–21570
  8. Chudasama Y, Robbins TW. Dopaminergic modulation of visual attention and working memory in the rodent prefrontal cortex. Neuropsychopharmacology. 2004;29(9):1628–1636
  9. Cooper, S.J., Dourish, C.T., 1990. An introduction to the concept of stereotypy and a historical perspective on the role of brain dopamine. In: Cooper, S.J., Dourish, C.T. (Eds.), Neurobiology of Stereotyped Behaviour. Clarendon Press, Oxford, pp. 1–24.
  10. Crawley JN. What’s wrong with my mouse?—Behavioral Phenotyping of Transgenic and Knockout Mice. New York: John Wiley & Sons; 2000;
  11. De Souza Silva MA, Mattern C, Hacker R, Nogueira PJ, Huston JP, Schwarting RK. Intranasal administration of the dopaminergic agonists l-DOPA, amphetamine, and cocaine increases dopamine activity in the neostriatum: a microdialysis study in the rat. J. Neurochem. 1997;68(1):233–239
  12. Denenberg VH, Kim DS, Palmiter RD. The role of dopamine in learning, memory, and performance of a water escape task. Behav. Brain Res. 2004;148(1/2):73–78
  13. Dere E, Huston JP, De Souza Silva MA. The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci. Biobehav. Rev. 2007;31(5):673–704
  14. Drago J, Gerfen CR, Lachowicz JE, Steiner H, Hollon TR, Love PE, et al. Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc. Natl. Acad. Sci. U.S.A. 1994;91(26):12564–12568
  15. Dumont M, Strazielle C, Staufenbiel M, Lalonde R. Spatial learning and exploration of environmental stimuli in 24-month-old female APP23 transgenic mice with the Swedish mutation. Brain Res. 2004;1024(1/2):113–121
  16. Ennaceur A, Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1. Behavioral data. Behav. Brain Res. 1988;31(1):47–59
  17. Ennaceur A, Michalikova S, Bradford A, Ahmed S. Detailed analysis of the behavior of Lister and Wistar rats in anxiety, object recognition and object location tasks. Behav. Brain Res. 2005;159(2):247–266
  18. Fiorillo CD, Tobler PN, Schultz W. Discrete coding of reward probability and uncertainty by dopamine neurons. Science. 2003;299(5614):1898–1902
  19. Floel A, Breitenstein C, Hummel F, Celnik P, Gingert C, Sawaki L, et al. Dopaminergic influences on formation of a motor memory. Ann. Neurol. 2005;58(1):121–130
  20. Floel A, Hummel F, Breitenstein C, Knecht S, Cohen LG. Dopaminergic effects on encoding of a motor memory in chronic stroke. Neurology. 2005;65(3):472–474
  21. Floel A, Garraux G, Xu B, Breitenstein C, Knecht S, Herscovitch P, et al. Levodopa increases memory encoding and dopamine release in the striatum in the elderly. Neurobiol. Aging. 2008;29:267–279
  22. Furio AM, Cutrera RA, Thea VC, Lloret SP, Riccio P, Caccuri RL, et al. Effect of melatonin on changes in locomotor activity rhythm of syrian hamsters injected with beta amyloid peptide 25–35 in the suprachiasmatic nuclei. Cell Mol. Neurobiol. 2002;22(5/6):699–709
  23. Garner JP, Mason GJ. Evidence for a relationship between cage stereotypies and behavioural disinhibition in laboratory rodents. Behav. Brain Res. 2002;136:83–92
  24. Goldman-Rakic PS. Working memory dysfunction in schizophrenia. J. Neuropsychiatry Clin. Neurosci. 1994;6(4):348–357
  25. Harper DG, Stopa EG, McKee AC, Satlin A, Fish D, Volicer L. Dementia severity and lewy bodies affect circadian rhythms in Alzheimer disease. Neurobiol. Aging. 2004;25(6):771–781
  26. Hotte M, Naudon L, Jay TM. Modulation of recognition and temporal order memory retrieval by dopamine D1 receptor in rats. Neurobiol. Learn. Mem. 2005;84(2):85–92
  27. Huitron-Resendiz S, Sanchez-Alavez M, Gallegos R, Berg G, Crawford E, Giacchino JL, et al. Age-independent and age-related deficits in visuospatial learning, sleep-wake states, thermoregulation and motor activity in PDAPP mice. Brain Res. 2002;928(1/2):126–137
  28. Huston JP, Oitzl MS. The relationship between reinforcement and memory: parallels in the rewarding and mnemonic effects of the neuropeptide substance P. Neurosci. Biobehav. Rev. 1989;13(2/3):171–180
  29. Huston JP, Wagner U, Hasenohrl RU. The tuberomammillary nucleus projections in the control of learning, memory and reinforcement processes: evidence for an inhibitory role. Behav. Brain Res. 1997;83(1/2):97–105
  30. Hyde LA, Kazdoba TM, Grilli M, Lozza G, Brusa R, Zhang Q, et al. Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice. Behav. Brain Res. 2005;160(2):344–355
  31. Irifune M, Nomoto M, Fukuda T. Effects of GBR 12909 on locomotor activity and dopamine turnover in mice: comparison with apomorphine. Eur. J. Pharmacol. 1995;272(1):79–85
  32. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, et al. A peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer’s disease. Nature. 2000;408(6815):979–982
  33. Janus C, Welzl H, Hanna A, Lovasic L, Lane N, St George-Hyslop P, et al. Impaired conditioned taste aversion learning in APP transgenic mice. Neurobiol. Aging. 2004;25(9):1213–1219
  34. Jones GH, Robbins TW. Differential effects of mesocortical, mesolimbic, and mesostriatal dopamine depletion on spontaneous, conditioned, and drug-induced locomotor activity. Pharmacol. Biochem. Behav. 1992;43(3):887–895
  35. Joyce JN, Kaeger C, Ryoo H, Goldsmith S. Dopamine D2 receptors in the hippocampus and the amygdala in Alzheimer’s disease. Neurosci. Lett. 1993;154:171–174
  36. Kemppainen N, Laine M, Laakso MP, Kaasinen V, Nagren K, Vahlberg T, et al. Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer’s disease. Eur. J. Neurosci. 2003;18(1):149–154
  37. Kim DS, Szczypka MS, Palmiter RD. Dopamine-deficient mice are hypersensitive to dopamine receptor agonists. J. Neurosci. 2000;20(12):4405–4413
  38. Knecht S, Breitenstein C, Bushuven S, Wailke S, Kamping S, Floel A, et al. Levodopa: faster and better word learning in normal humans. Ann. Neurol. 2004;56(1):20–26
  39. Lalonde R, Dumont M, Staufenbiel M, Sturchler-Pierrat C, Strazielle C. Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation. Brain Res. 2002;956:36–44
  40. Lanari A, Amenta F, Silvestrelli G, Tomassoni D, Parnetti L. Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer’s disease. Mech. Ageing Dev. 2006;127(2):158–165
  41. Lesne S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature. 2006;440(7082):352–357
  42. Lewejohann, L., 2004. Digital image processing in behavioral sciences. http://www.phenotyping.com/digital.html.
  43. Li J, Zhu M, Manning-Bog AB, Di Monte DA, Fink AL. Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson’s and Alzheimer’s disease. FASEB J. 2004;18(9):962–964
  44. Lovasic L, Bauschke H, Janus C. Working memory impairment in a transgenic amyloid precursor protein TgCRND8 mouse model of Alzheimer’s disease. Genes Brain Behav. 2005;4(3):197–208
  45. Luo Y, Roth GS. The roles of dopamine oxidative stress and dopamine receptor signaling in aging and age-related neurodegeneration. Antioxid Redox Signal. 2000;2(3):449–460
  46. Mahlberg R, Kunz D, Sutej I, Kühl KP, Hellweg R. Melatonin treatment of day-night rhythm disturbances and sundowning in Alzheimer disease. J. Clin. Psychopharmacol. 2004;24(4):456–458
  47. Martin P, Bateson P. Measuring Behaviour: An Introductory Guide. 2nd ed.. Cambridge: Cambridge University Press; 1993;
  48. Martin SJ, Clark RE. The rodent hippocampus and spatial memory: from synapses to systems. Cell Mol. Life Sci. 2007;64(4):401–431
  49. Mason GJ. Stereotypies: a critical review. Anim. Behav. 1991;41:1015–1037
  50. Mason GJ. Stereotypies and suffering. Behav. Processes. 1991;25:103–115
  51. Mattay VS, Tessitore A, Callicott JH, Bertolino A, Goldberg TE, Chase TN, et al. Dopaminergic modulation of cortical function in patients with Parkinson’s disease. Ann. Neurol. 2002;51(2):156–164
  52. Meguro K, Meguro M, Tanaka Y, Akanuma K, Yamaguchi K, Itoh M. Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer’s disease. J. Geriatr. Psychiatry Neurol. 2004;17(2):61–67
  53. Murphy BL, Arnsten AF, Goldman-Rakic PS, Roth RH. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc. Natl. Acad. Sci. U.S.A. 1996;93(3):1325–1329
  54. Murphy BL, Arnsten AF, Jentsch JD, Roth RH. Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment. J. Neurosci. 1996;16(23):7768–7775
  55. Nader K, LeDoux JE. Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations. Behav. Neurosci. 1999;113(5):891–901
  56. Nazarali AJ, Reynolds GP. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer’s disease: a postmortem study. Cell Mol. Neurobiol. 1992;12(6):581–587
  57. Nieoullon A. Dopamine and the regulation of cognition and attention. Prog. Neurobiol. 2002;67(1):53–83
  58. Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O, et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature. 1997;385(6617):634–636
  59. Pavlis M, Feretti C, Levy A, Gupta N, Linster C. l-DOPA improves odor discrimination learning in rats. Physiol. Behav. 2006;87(1):109–113
  60. Pizzolato G, Chierichetti F, Fabbri M, Cagnin A, Dam M, Ferlin G, et al. Reduced striatal dopamine receptors in Alzheimer’s disease: Single photon emission tomography study with the D2 tracer123I-IBZM. Neurology. 1996;47(4):1065–1068
  61. Robbins, T.W., Mittleman, G., O’Brien, J., Winn, P., 1990. The neuropsychological significance of stereotypy induced by stimulant drugs. In: Cooper, S.J., Dourish, C.T. (Eds.), Neurobiology of Stereotyped Behaviour. Clarendon Press, Oxford, pp. 25–63.
  62. Roberson ED, Mucke L. 100 years and counting: prospects for defeating Alzheimer’s disease. Science. 2006;314(5800):781–784
  63. Sawaguchi T, Goldman-Rakic PS. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science. 1991;251(4996):947–950
  64. Schultz W. Getting formal with dopamine and reward. Neuron. 2002;36(2):241–263
  65. Seamans JK, Floresco SB, Phillips AG. D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat. J. Neurosci. 1998;18(4):1613–1621
  66. Sethy VH, Francis JW. Regulation of brain acetylcholine concentration by muscarinic receptors. J. Pharmacol. Exp. Ther. 1988;246(1):243–248
  67. Skene DJ, Swaab DF. Melatonin rhythmicity: effect of age and Alzheimer’s disease. Exp. Gerontol. 2003;38:199–206
  68. Stam CJ, de Bruin JP, van Haelst AM, van der Gugten J, Kalsbeek A. Influence of the mesocortical dopaminergic system on activity, food hoarding, social-agonistic behavior, and spatial delayed alternation in male rats. Behav. Neurosci. 1989;103(1):24–35
  69. Storga D, Vrecko K, Birkmayer JG, Reibnegger G. Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients. Neurosci. Lett. 1996;203(1):29–32
  70. Tanaka Y, Meguro K, Yamaguchi S, Ishi H, Watanuki S, Funaki Y, et al. Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer’s disease. Ann. Nucl. Med. 2003;17(7):567–573
  71. Tassin JP, Stinus L, Simon H, Blanc G, Thierry AM, Le Moal M, et al. Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic innervation in the rat. Brain Res. 1978;141(2):267–281
  72. Tate B, Aboody-Guterman KS, Morris AM, Walcott EC, Majocha RE, Marotta CA. Disruption of circadian regulation by brain grafts that overexpress Alzheimer beta/A4 amyloid. Proc. Natl. Acad. Sci. U.S.A. 1992;89(15):7090–7094
  73. Touma C, Ambrée O, Görtz N, Keyvani K, Lewejohann L, Palme R, et al. Age- and sex-dependent development of adrenocortical hyperactivity in a transgenic mouse model of Alzheimer’s disease. Neurobiol. Aging. 2004;25(7):893–904
  74. Van Dam D, D’Hooge R, Staufenbiel M, Van Ginneken C, Van Meir F, De Deyn PP. Age-dependent cognitive decline in the APP23 model precedes amyloid deposition. Eur. J. Neurosci. 2003;17(2):388–396
  75. Van Someren EJ, Hagebeuk EE, Lijzenga C, Scheltens P, de Rooij SE, Jonker C, et al. Circadian rest-activity rhythm disturbances in Alzheimer’s disease. Biol. Psychiatry. 1996;40(4):259–270
  76. Van Someren EJW. Circadian and sleep disturbances in the elderly. Exp. Gerontol. 2000;35:1229–1237
  77. Vloeberghs E, van Dam D, Engelborghs S, Nagels G, Staufenbiel M, de Deyn PP. Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances. Eur. J. Neurosci. 2004;200:2757–2766
  78. Volicer L, Harper DG, Manning BC, Goldstein R, Satlin A. Sundowning and circadian rhythms in Alzheimer’s disease. Am. J. Psychiatry. 2001;158(5):704–711
  79. Volkow ND, Gur RC, Wang GJ, Fowler JS, Moberg PJ, Ding YS, et al. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am. J. Psychiatry. 1998;155(3):344–349
  80. Waelti P, Dickinson A, Schultz W. Dopamine responses comply with basic assumptions of formal learning theory. Nature. 2001;412(6842):43–48
  81. Walsh DM, Selkoe DJ. Deciphering the molecular basis of memory failure in Alzheimer’s disease. Neuron. 2004;44(1):181–193
  82. Walsh RN, Cummins RA. The open-field test: a critical review. Psychol. Bull. 1976;83:482–504
  83. Wiedenmayer C. Effect of cage size on ontogeny of stereotyped behaviour in gerbils. Appl. Anim. Behav. Sci. 1996;47:225–233
  84. Williams GV, Goldman-Rakic PS. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature. 1995;376(6541):572–575
  85. Winblad B, Hardy J, Backman L, Nilsson LG. Memory function and brain biochemistry in normal aging and in senile dementia. Ann. N. Y. Acad. Sci. 1985;444:255–268
  86. Wise RA. Addictive drugs and brain stimulation reward. Annu. Rev. Neurosci. 1996;19:319–340
  87. Witting W, Kwa IH, Eikelenboom P, Mirmiran M, Swaab DF. Alterations in the circadian rest-activity rhythm in aging and Alzheimer’s disease. Biol. Psychiatry. 1990;27(6):563–572
  88. Würbel H, Stauffacher M, von Holst D. Stereotypies in laboratory mice—quantitative and qualitative description of the ontogeny of ‘wire-gnawing’ and ‘jumping’ in Zur:ICR and Zur:ICR nu.. Ethology. 1996;102:371–385
  89. Zahrt J, Taylor JR, Mathew RG, Arnsten AF. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J. Neurosci. 1997;17(21):8528–8535

PII: S0197-4580(07)00443-5

doi: 10.1016/j.neurobiolaging.2007.11.010

Neurobiology of Aging
Volume 30, Issue 8 , Pages 1192-1204 , August 2009

Article Tools

* Image Usage & Resolution